Last reviewed · How we verify

NCT07197099: TPE

Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease

Recruiting now Last updated 18 November 2025
What this trial tests

trial in Neurological Autoimmune Diseases in 60 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
30 October 2025
31 December 2025

Quick facts

Lead sponsorAl-Azhar University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment60
Start date1 January 2025
Primary completion30 October 2025
Estimated completion31 December 2025
Sites1 location across Egypt

Conditions studied

Sponsor

Al-Azhar University

Who can join

Eligibility, any sex, with Neurological Autoimmune Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurological Autoimmune Diseases

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07197099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing